7 completed, 3 unknown, 2 recruiting. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 7, Unknown 3, Recruiting 2 |
Follow Uterine Cervical Dysplasia: new trials by email Literature Review of Uterine Cervical Dysplasia trials Research Report on Uterine Cervical Dysplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV Human papillomavirus 9-valent vaccine, recombinant, human papillomavirus vaccine, recombinant - Papillomavirus Vaccines, Human Immunodeficiency Virus | Phase 4 | Recruiting | Louisiana State University Health Sciences Center in New Orleans | 250 | 2022-11-30 | 2025-04-18 |
| A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) Nonavalent HPV vaccine (9vHPV/Gardasil-9™). - Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections | Phase 4 | Recruiting | Miquel Angel Pavon Ribas | 69 | 2022-09-13 | 2026-02-23 |
| "Lactobacillus Crispatus M247, LSIL and Microbiota" Lactobacillus Crispatus M247 - Vaginal Flora Imbalance, ASC-US | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 90 | 2021-06-16 | 2023-04-11 |
| Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin® - Cervical Intraepithelial Neoplasia, Cervical Cancer | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 540 | 2020-05-01 | 2022-06-29 |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study HPV (Types 16, 18) Vaccine, Adsorbed - Cervical Intraepithelial Neoplasia | Phase 4 | Completed | GlaxoSmithKline | 6051 | 2018-08-22 | 2024-03-15 |
| FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program CERVARIX, GARDASIL - Cervical Intraepithelial Neoplasia, HPV-Related Cervical Carcinoma | Phase 4 | Completed | Instituto Nacional de Salud Publica, Mexico | 3000 | 2017-01-03 | 2020-08-10 |
| Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization Bupivacaine, Adrenaline - Cervical Intraepithelial Neoplasia | Phase 4 | Completed | Helse Fonna | 34 | 2015-05-01 | 2016-08-19 |
| The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Tachosil - Cervical Intraepithelial Neoplasia, Cervical Cancer | Phase 4 | Unknown | Asan Medical Center | 268 | 2015-01-01 | 2017-05-31 |
| V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) V501 - Cervical Cancer, Cervical Intraepithelial Neoplasia | Phase 4 | Completed | Merck Sharp & Dohme LLC | 1030 | 2011-11-25 | 2018-11-28 |
| Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Human Papillomavirus Vaccine - Inflammatory Bowel Disease, Uterine Cervical Dysplasia | Phase 4 | Completed | Mayo Clinic | 15 | 2010-02-01 | 2012-10-23 |
| Can Alternative Treatment Have an Impact on Cervical Dysplasia? Mindfulness meditation, No meditation, Controls - Cervical Dysplasia | Phase 4 | Unknown | University of Copenhagen | 200 | 2009-03-01 | 2010-01-14 |
| Management of Cervical Intraepithelial Neoplasia Grade 2 Excision of the lesion, Follow-up for spontaneous regression of the lesion - Cervical Intraepithelial Neoplasia | Phase 4 | Completed | Universidade Cidade de Sao Paulo | 90 | 2003-03-01 | 2010-01-11 |
Uterine Cervical Neoplasms (6) · Papillomavirus Infections (4) · Acquired Immunodeficiency Syndrome (1) · Adenocarcinoma in Situ (1) · Atypical Squamous Cells of the Cervix (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Infections (1) · Inflammatory Bowel Diseases (1) · Persistent Infection (1) · Squamous Intraepithelial Lesions of the Cervix (1)
Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Genital Diseases (12) · Genital Diseases, Female (12) · Neoplasms (12) · Precancerous Conditions (12) · Urogenital Diseases (12) · Uterine Cervical Diseases (12) · Uterine Diseases (12) · Genital Neoplasms, Female (6) · Neoplasms by Site (6) · Urogenital Neoplasms (6) · Uterine Neoplasms (6) · Pathological Conditions, Signs and Symptoms (5) · Communicable Diseases (4)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (4) · Papillomavirus Vaccines (3) · Vaccines (2) · Bupivacaine (1) · Epinephrine (1) · Human Papillomavirus Recombinant Vaccine nonavalent (1) · Mindfulness (1) · TachoSil (1) · human papillomavirus vaccine, L1 type 16, 18 (1)
Asan Medical Center (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · GlaxoSmithKline (1) · Helse Fonna (1) · Instituto Nacional de Salud Publica, Mexico (1) · Louisiana State University Health Sciences Center in New Orleans (1) · Mayo Clinic (1) · Merck Sharp & Dohme LLC (1) · Miquel Angel Pavon Ribas (1) · Universidade Cidade de Sao Paulo (1) · University of Copenhagen (1) · Xiamen Innovax Biotech Co., Ltd (1)
China (2) · United States (2) · Brazil (1) · Denmark (1) · Italy (1) · Mexico (1) · Norway (1) · South Korea (1) · Spain (1)
Ana C Guedes, MD, PhD (1) · Jeanne Tung, MD (1) · Jennifer E Cameron, PhD (1) · Kari J Sirjanen, MD, PhD (1) · Luis C Zeferino, MD, PhD (1) · Michael E Hagensee, MD, PhD (1) · Sylvia F Brenna, MD, PhD (1) · Yuemei Hu (1)
PMID 30203440, PMID 30879979, PMID 38768231, PMID 39842025, PMID 41276263
2014 (1), 2015 (1)